Cannabinoids: Therapeutic Perspectives for Management of Orofacial Pain, Oral Inflammation and Bone Healing—A Systematic Review
International Journal of Molecular Sciences · 16.04.2025 · 26 (8) · 3766
DOI: 10.3390/ijms26083766 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.04.2025. Verfasst von Maria Domenica Campana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Reproductive Science and Dentistry, University of Naples Federico II, 80138 Naples, Italy. Hauptthemen laut MEDLINE: Facial Pain, Cannabinoids, Inflammation. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cannabinoids, particularly cannabidiol (CBD) and tetrahydrocannabinol (THC), have been increasingly studied for their therapeutic applications in various medical fields. This systematic review aims to explore their role in oral surgery, focusing on pain management, inflammation control, and bone regeneration. A systematic review was conducted using the PRISMA framework to identify relevant studies from the PubMed, Scopus, and Web of Science databases published up to November 2024. The review included clinical and preclinical studies investigating the effects of cannabinoids on orofacial pain, oral inflammation, and bone healing. Data on study design, cannabinoid types, and relevant outcomes were extracted and analyzed. CBD was the most commonly studied compound, with other studies evaluating CB1/CB2 receptor agonists, THC, and cannabis smoke. Clinical trials showed mixed results: some studies found CBD effective in reducing dental or myofascial pain, while others found limited or non-superior outcomes compared to standard treatments (e.g., NSAIDs, corticosteroids). Among the four RCTs, three had a low risk of bias, and one moderate; all nine animal studies had a high risk of bias. in conclusion, preclinical and clinical studies suggest that cannabinoids represent a promising non-opioid alternative for pain management and for oral inflammation. Although some evidence suggests potential benefits of cannabinoids, particularly CBD, in oral health contexts, findings are derived from heterogeneous studies—many with high risk of bias. More high-quality, standardized clinical trials are necessary before recommending cannabinoids for routine dental practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Reproductive Science and Dentistry, University of Naples Federico II, 80138 Naples, Italy.
ORCID-Profile: Gilberto Sammartino, Roberta Gasparro
Zitieren
APA
Campana, M. D., de Paolis, G., Sammartino, G., Bucci, P., Aliberti, A., & Gasparro, R. (2025). Cannabinoids: Therapeutic Perspectives for Management of Orofacial Pain, Oral Inflammation and Bone Healing—A Systematic Review. International Journal of Molecular Sciences, 26(8), 3766. https://doi.org/10.3390/ijms26083766
Vancouver
Campana MD, de Paolis G, Sammartino G, Bucci P, Aliberti A, Gasparro R. Cannabinoids: Therapeutic Perspectives for Management of Orofacial Pain, Oral Inflammation and Bone Healing—A Systematic Review. International Journal of Molecular Sciences. 2025;26(8):3766. doi:10.3390/ijms26083766
BibTeX
@article{Campana2025,
author = {Campana, Maria Domenica and de Paolis, Giulio and Sammartino, Gilberto and Bucci, Paolo and Aliberti, Angelo and Gasparro, Roberta},
title = {Cannabinoids: Therapeutic Perspectives for Management of Orofacial Pain, Oral Inflammation and Bone Healing—A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3766},
doi = {10.3390/ijms26083766}
}
EUVIMED